Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 18Recruiting 6Unknown 4Not yet recruiting 4Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other neoplasm 1Other 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Leukemia 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 122Cytarabine 112fludarabine 91fludarabine phosphate 80Rituximab 75Azacitidine 75venetoclax 55Methotrexate 52Filgrastim 48Whole-Body Irradiation 45Busulfan 45Tacrolimus 35Etoposide 35Mycophenolic Acid 34Lenalidomide 32Imatinib Mesylate 32Antilymphocyte Serum 32Granulocyte Colony-Stimulating Factor 31Decitabine 31Peripheral Blood Stem Cell Transplantation 29Dexamethasone 29Cyclosporine 29Vincristine 26Melphalan 26Clofarabine 25Alemtuzumab 25Mitoxantrone 24Stem Cell Transplantation 22Radiotherapy 22Dasatinib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Exercise × Other hematologic neoplasm × Clear all
NCT04081298 2023-07-03

MiVSEEV

Fred Hutchinson Cancer Center

Phase NA Terminated
20 enrolled 34 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT02234037 2017-01-30

Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60

Emory University

Phase 1 Terminated
3 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡